Pfizer Inc vs Packaging Corporation of America — how do they compare? Pfizer Inc trades at $27.88 (market cap $158.39B), while Packaging Corporation of America trades at $227.95 (market cap $20.67B). The key difference: Pfizer Inc is far larger — about 7.7× Packaging Corporation of America's market cap, and Pfizer Inc pays the higher dividend (6.19%). Which is the better fit depends on your goals.
| PFE | PKG | |
|---|---|---|
Market Cap | $158.39B | $20.67B |
Volume | 29,869,932 | — |
Sector | Health | Technology |
52-Week High | $29.02 | $257.43 |
52-Week Low | $23.60 | $191.68 |
Enterprise Value | $209.89B | $24.48B |
Dividend Yield | 6.19% | 2.59% |
Signals from Pluang's Aura AI — not financial advice
Pfizer (PFE) trades at $27.78, down 2.36% today, with a consensus price target of $28.33 suggesting modest upside. The stock shows mixed technical signals with bullish moving averages but neutral oscillators. Recent earnings have consistently beaten expectations, though revenue declined from pandemic peaks. The company maintains strong cash flow generation and a solid dividend yield of approximately 3.1%.
Pfizer presents a value opportunity with reasonable valuation metrics and dividend stability, but faces headwinds from post-COVID revenue normalization and patent expirations. The company's pipeline progress in obesity and oncology could drive future growth, though execution risks remain. Analyst sentiment leans cautious with 59% hold ratings.
Packaging Corporation of America (PKG) trades at $231.99, down 2.22% with bearish technical signals despite recent earnings beats. The stock shows mixed fundamentals with a P/E of 30.13 above industry averages, while profitability metrics indicate solid ROE of 14.79% amid margin pressures. Recent news highlights dividend declarations and CEO participation in industry conferences, though cash flow trends show negative net flows driven by significant capital investments.
PKG presents a cautious outlook with analyst consensus leaning hold (57.69%) despite a $272.83 price target suggesting 17.6% upside. Investment appeal hinges on execution amid cost headwinds, while risks include margin compression and competitive pressures. The technical setup near support at $230 requires monitoring for potential breakdown or reversal signals.
Trailing returns across standard periods
Latest headlines on both assets
Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.
Read more on PFE →Packaging Corporation of America is a leading producer of containerboard and corrugated packaging products in North America. The company also produces white papers, which include printing and writing papers. PKG operates as an integrated manufacturer, with a strong focus on high-quality and sustainable packaging solutions for e-commerce, food and beverage, and other industrial and consumer markets.
Read more on PKG →